Hizentra
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
44206-451 -
Package NDC
44206-451-01 -
Application number
BLA125350 -
SPL ID
411c01a7-0ae7-45d2-8b4c-cbe99a2ba264 -
SPL set ID
7b58f5ff-0316-49a3-b585-1f6003ddb953 -
UNII
66Y330CJHS -
RxCUI
1809061 -
RxCUI
1809063 -
RxCUI
1809066 -
RxCUI
1809067 -
RxCUI
1809068 -
RxCUI
1809069 -
RxCUI
1809076 -
RxCUI
1809077 -
RxCUI
2268103 -
RxCUI
2268105 -
RxCUI
2268108 -
RxCUI
2268109 -
RxCUI
2287158 -
RxCUI
2287159 -
RxCUI
2670628 -
RxCUI
2670629
What the source publishes
- Labeler
- CSL Behring AG
- Active ingredients
- HUMAN IMMUNOGLOBULIN G
- Form
- LIQUID
- Routes
- SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- BLA
- Product type
- PLASMA DERIVATIVE
Names this record is found by
Complete source data
{
"name": "Hizentra",
"splId": "411c01a7-0ae7-45d2-8b4c-cbe99a2ba264",
"labels": [
{
"setId": "7b58f5ff-0316-49a3-b585-1f6003ddb953",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7b58f5ff-0316-49a3-b585-1f6003ddb953",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=7b58f5ff-0316-49a3-b585-1f6003ddb953"
}
],
"routes": [
"SUBCUTANEOUS"
],
"labeler": "CSL Behring AG",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-DOSE in 1 CARTON (44206-451-01) / 5 mL in 1 VIAL, SINGLE-DOSE (44206-451-90)",
"package_ndc": "44206-451-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20111003"
}
],
"productId": "44206-451_411c01a7-0ae7-45d2-8b4c-cbe99a2ba264",
"useDomain": "unknown",
"dosageForm": "LIQUID",
"productNdc": "44206-451",
"deaSchedule": null,
"genericName": "HUMAN IMMUNOGLOBULIN G",
"productType": "PLASMA DERIVATIVE",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "HUMAN IMMUNOGLOBULIN G",
"strength": ".2 g/mL"
}
],
"applicationNumber": "BLA125350",
"marketingCategory": "BLA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20111003",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "unknown",
"harmonizedIdentifiers": {
"nui": [
"N0000184165",
"N0000183365",
"N0000184008",
"M0011122"
],
"unii": [
"66Y330CJHS"
],
"rxcui": [
"1809061",
"1809063",
"1809066",
"1809067",
"1809068",
"1809069",
"1809076",
"1809077",
"2268103",
"2268105",
"2268108",
"2268109",
"2287158",
"2287159",
"2670628",
"2670629"
],
"spl_set_id": [
"7b58f5ff-0316-49a3-b585-1f6003ddb953"
],
"pharm_class_cs": [
"Immunoglobulins [CS]"
],
"pharm_class_pe": [
"Passively Acquired Immunity [PE]"
],
"pharm_class_epc": [
"Human Immunoglobulin G [EPC]"
],
"pharm_class_moa": [
"Antigen Neutralization [MoA]"
],
"manufacturer_name": [
"CSL Behring AG"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20261231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:44206-451_411c01a7-0ae7-45d2-8b4c-cbe99a2ba264"